article June 14, 2021
Widening the Lens: From Patient Engagement to Community Engagement
“Addressing the alarming gap in time-to-market primarily driven by prolonged patient accrual requires expanding awareness and access to clinical research as a care option within communities.” In this PharmaVOICE article, Javara Patient Experience Advisor Alycia James, and VP, Partnership Development Amanda Wright, dive into what it means to expand our perspective, focusing not only on the patients but on their communities as well, and how greater community engagement impacts the landscape of clinical research.
Javara is the leading Integrated Research Organization (IRO) partnering with large healthcare organizations in local communities across the US to integrate clinical research into clinical care. Our access to broad diverse patient populations through their trusted physicians ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. Our team includes experienced clinical research leaders who have collectively led 10,000+ trials and engaged 200,000+ patients in clinical trials. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time. For more information, please visit Javararesearch.com.
Javara Media Contact: